Premier Alternatives

Character Biosciences

Jersey City, NJ · Founded 2018 · Privately Held (backing)

Developer of precision medicine designed to transform drug development for progressive, polygenic diseases. Character Biosciences is based in Jersey City, NJ and was founded in 2018. It was valued at $203 million at its later-stage round in Sep 2025, the last priced event on record. It has raised $137 million across 2 recorded rounds; the latest was an $8.9 million early-stage round in Sep 2025.

PMV mark · valuation
$203.0M
Oct 2026
Priced at
its later-stage round
Sep 2025
Total raised
$136.9M
Last round
Early Stage VC
Sep 2025

Character Biosciences key facts

as of Oct 2026
  • Developer of precision medicine designed to transform drug development for progressive, polygenic diseases.
  • Character Biosciences is valued at approximately $203.0M as of Oct 2026, set at its later-stage round, Sep 2025; nothing has traded since, per PrivateMarketView’s mark.
  • It has raised $136.9M across 2 recorded rounds; the latest was Early Stage VC ($8.9M) in Sep 2025.
  • Notable investors include Industry Ventures, Innovation Endeavors, Catalio Capital Management, S32, Duke Capital Partners — 18 tracked in total.
  • Character Biosciences has filed 2 Form Ds with the SEC, most recently Sep 2025 ($8.9M sold to 4 investors).
  • Status: Privately Held (backing).
PrivateMarketView mark
LOW confidence
$203.0M

Valued at $203.0M at its later-stage round, Sep 2025. Nothing has traded since.

set by its last priced roundas of Oct 2026question about this number?
Free account
More of Character Biosciences with a free account
  • ·The complete investor list: 18 names
  • ·Watch Character Biosciences: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

Character Biosciences funding rounds

2 rounds
Sep 2025Early Stage VC$8.9MSEC filing▮
Mar 2025Early Stage VC$48.2MSEC filing▮
Full funding history →

Character Biosciences valuation

Character Biosciences was valued at $203 million at its later-stage round in Sep 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.

How much has Character Biosciences raised?

Character Biosciences has raised $137 million in total; 2 of its rounds are on record. The largest on record was an $8.9 million early-stage round in Sep 2025.

Character Biosciences has filed 2 Form Ds with the SEC, most recently in Sep 2025 ($8.9 million sold to 4 investors).

Character Biosciences investors

18 investors are on record for Character Biosciences, including Industry Ventures, Innovation Endeavors, Catalio Capital Management and S32. By type, the record holds 8 venture capital firms and 1 family office. The early-stage round in Sep 2025 drew 4 investors.

About Character Biosciences

Developer of precision medicine designed to transform drug development for progressive, polygenic diseases. The company integrates genomics, clinical data, and AI-driven modeling to develop targeted therapies for dry age-related macular degeneration and primary open-angle glaucoma, enabling clinicians, researchers, and patients to create effective treatments, improve prediction of disease course, and focus therapies on individual patient needs.

Sector
Healthcare
HQ
Jersey City, NJ, United States
Founded
2018
Employees
48
Ownership
Privately Held (backing)

Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.